[ad_1]
A vaccine for malaria has been approved by the World Health Organisation in what is potentially a landmark breakthrough in the fight against the disease. The vaccine is called Mosquirix and has been developed by British pharmaceutical company GlaxoSmithKline.
According to the World Health Organisation (WHO), in 2019 there were 229 million cases of malaria worldwide. The estimated number of deaths in the same year was 409,000, and children under the age of five are the most vulnerable group.
Malaria is transmitted by parasites passed to people through the bites of infected female Anopheles mosquitoes.
Key advisors for the WHO have recommended that the vaccine is rolled out. The funding for the vaccine will now be decided upon by the Vaccine Alliance.
But what are the five most common symptoms of malaria?
READ MORE: High cholesterol: Five warning signs in your legs
[ad_2]
